BioCentury
ARTICLE | Company News

Cohesion Technologies biomaterial/skin/wound news

November 19, 2001 8:00 AM UTC

CSON reduced its headcount by 20%, resulting in expected annual savings of $1.5 million, and will focus its resources on its CoStasis surgical hemostat and CoSeal surgical sealant platform technolog...